000			01523 a2200397 4500
005			20250514215443.0
264		0	_c20050526
008			200505s 0 0 eng d
022			_a0012-1630
024	7		_a10.1002/dev.20039 _2doi
040			_aNLM _beng _cNLM
100	1		_aGoodwin, Gregory A
245	0	0	_aDevelopmental changes in the behavioral and autonomic effects of kappa opioid receptor stimulation of the midbrain periaqueductal gray. _h[electronic resource]
260			_bDevelopmental psychobiology _cJan 2005
300			_a47-56 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer _xpharmacology
650	0	4	_aAge Factors
650	0	4	_aAnalgesics, Non-Narcotic _xpharmacology
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimal Communication
650	0	4	_aAnimals
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aMale
650	0	4	_aPeriaqueductal Gray _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Long-Evans
650	0	4	_aReceptors, Opioid, kappa _xdrug effects
650	0	4	_aWater _xadministration & dosage
700	1		_aBarr, Gordon A
773	0		_tDevelopmental psychobiology _gvol. 46 _gno. 1 _gp. 47-56
856	4	0	_uhttps://doi.org/10.1002/dev.20039 _zAvailable from publisher's website
999			_c15367280 _d15367280